This special series on “Evolutions in the Management of Advanced Ovarian Cancer” was edited by Dr. Hooman Soleymani Majd, MD, MRCOG, BSCCP, from Department of Gynaecologic Oncology, Oxford University Hospital NHS Trust, Churchill Hospital, Oxford, UK.
Editorial on Evolutions in the Management of Advanced Ovarian Cancer
Evolutions in the management of advanced ovarian cancer
Review Article on Evolutions in the Management of Advanced Ovarian Cancer
Narrative review of novel chemotherapeutic agents in management of ovarian cancer
The challenges and opportunities in ovarian cancer relapse—the role of second and third-line chemotherapy: literature review
The histological value of chemotherapy response score in advanced ovarian cancer—histopathological challenges
The role of exploratory laparoscopy in surgical planning for ultra-radical surgery for ovarian cancer: a narrative review
The principles of safe and efficacious upper abdominal surgery
The role of multiple bowel resections in advanced ovarian cancer: survival and surgical outcomes—a narrative review
A narrative review of the role of anaesthesia and peri-operative medicine in improving outcomes after surgery for advanced ovarian cancer
Role of immunotherapy in ovarian cancer: a narrative review
Disclosure:
The series “Evolutions in the Management of Advanced Ovarian Cancer” was commissioned by the editorial office, Gynecology and Pelvic Medicinewithout any sponsorship or funding. Hooman Soleymani Majd served as the unpaid Guest Editor for the series.